9069 Results

Congress Abstract

Early outcomes of stereotactic MR-guided adaptive radiation therapy in 54 high-risk lung tumors

Authors: Finazzi|, Tobias(1)*[t.finazzi@vumc.nl];Haasbeek|, Cornelis(1);Palacios|, Miguel(1);Spoelstra|, Femke(1);Admiraal|, Marjan(1);Bruynzeel|, Anna(1);Slotman|, Berend(1);Lagerwaard|, Frank(1);Senan|, Suresh(1);
(1)Amsterdam University Medical Centers VUmc location, Department of Radiation Oncology, Amsterdam, The Netherlands;
Show Affiliations

Congress Abstract

Multicenter study of stereotactic body radiotherapy in non-small cell lung cancer (KROG 17-09)

Authors: Park|, Seung-gyu(1)*[seungkyu0813@hanmail.net];Kim|, Jin Hee(1);Ahn|, Yong Chan (2);Noh|, Jae Myung (2);Kim|, Woo Chul (3);Kang|, Min Kyu (4);Cho|, Jae Ho (5);Kim|, Jae Sung (6);Kong|, Moonkyoo(7);Yea|, Ji Woon(8);Kim|, Yeon Sil (9);Choi|, Kyu Hye (9);Yeo|, Seung Gu (10);
(1)Keimyung University Dongsan Medical Center, Radiation oncology, Daegu, Korea Republic of;(2)Samsung Medical Center, Radiation Oncology, Seoul, Korea Republic of;(3)Inha University Hospital, Radiation Oncology, Incheon, Korea Republic of;(4)School of Medicine- Kyungpook National University, Radiation Oncology, Daegu, Korea Republic of;(5)Yonsei University College of Medicine, Radiation Oncology, Seoul, Korea Republic of;(6)Seoul National University Bundang Hospital, Radiation Oncology, Seongnam, Korea Republic of;(7)Kyung Hee University Medical Center, Radiation Oncology, Seoul, Korea Republic of;(8)Yeungnam University College of Medicine, Radiation Oncology, Daegu, Korea Republic of;(9)College of Medicine- The Catholic University, Radiation Oncology, Seoul, Korea Republic of;(10)Soonchunhyang University College of Medicine, Radiation Oncology, Cheonan, Korea Republic of;
Show Affiliations

Congress Abstract

Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3

Authors: POST|, Cathalijne(1)*[C.C.B.Post@lumc.nl];de Boer|, Stephanie M(1);Powell|, Melanie E(2);Mileshkin|, Linda(3);Katsaros|, Dionyssios(4);Bessette|, Paul(5);Haie-Meder|, Christine(6);Ottevanger|, Petronella B(7);Ledermann|, Jonathan A(8);Khaw|, Pearly(9);D'Amico|, Romerai(10);Fyles|, Anthony(11);Baron|, Marie-Helene(12);Kitchener|, Henry C(13);Nijman|, Hans W(14);Lutgens|, Ludy CHW(15);Brooks|, Susan(16);Jürgenliemk-Schulz|, Ina M(17);Feeney|, Amanda(8);Nout|, Remi A(1);Verhoeven-Adema|, Karen W(18);Smit|, Vincent THBM(19);Putter|, Hein(20);Creutzberg|, Carien L(1);
(1)Leiden University Medical Center, Radiation Oncology, Leiden, The Netherlands;(2)Barts Health NHS Trust, Clinical Oncology, London, United Kingdom;(3)Peter MacCallum Cancer Centre, Cancer Medicine, Melbourne, Australia;(4)Città della Salute and S Anna Hospital, Surgical Sciences, Torino, Italy;(5)University of Sherbrooke, Obstetrics and Gynaecology, Sherbrooke, Canada;(6)Institus Gustave Roussy, Radiotherapy, Villejuif, France;(7)Radboudumc, Medical Oncology, Nijmegen, The Netherlands;(8)UCL Cancer Institute, Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom;(9)Peter MacCallum Cancer Center, Radiation Oncology, Melbourne, Australia;(10)Azienda Ospedaliera della Provincia di Lecco, Radiotherapy, Lecco, Italy;(11)Princess Margaret Cancer Centre, Radiation Oncology, Toronto, Canada;(12)Centre Hospitalier Régional Universitaire de Besançon, Radiotherapy, Besançon, France;(13)University of Manchester, Institute of Cancer Sciences, Manchester, United Kingdom;(14)University Medical Center Groningen, Gynaecologic Oncology, Groningen, The Netherlands;(15)MAASTRO, Radiation Oncology, Maastricht, The Netherlands;(16)Auckland City Hospital, Radiation Oncology, Auckland, New Zealand;(17)University Medical Center Utrecht, Radiation Oncology, Utrecht, The Netherlands;(18)Comprehensive Cancer Center Netherlands, Central Data Management and Trial Coordination, Leiden, The Netherlands;(19)Leiden University Medical Center, Pathology, Leiden, The Netherlands;(20)Leiden University Medical Center, Medical Statistics, Leiden, The Netherlands;
Show Affiliations

Congress Abstract

Hypofractionated image guided re-irradiation in head - neck cancers; an Indian experience

Authors: Talapatra|, Kaustav(1)*[kaustee@gmail.com];Chadha|, Pranav (2); Deshpande|, Mandar(3);Mistry |, Rajesh(3);Vadgaonkar|, Rohit(2);Mhatre|, Vaibhav(2);Pilakkal|, Shaju(4);Goyle|, Sandeep(5);Limaye|, Sewanti(5);Shaikh|, Imran(6);Badhwar|, Sanjiv(7);
(1)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Radiation Oncology -, Mumbai, India;(2)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Radiation Oncology, Mumbai, India;(3)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Surgical Oncology, Mumbai, India;(4)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute-, Radiation Oncology, Mumbai, India;(5)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Medical Oncology, Mumbai, India;(6)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Medical Onocology, Mumbai, India;(7)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Otorhinolaryngology, Mumbai, India;
Show Affiliations

Congress Abstract

C-reactive protein-to-albumin ratio is a predictive marker for anal squamous cell carcinoma

Authors: Martin|, Daniel(1)*[daniel.martin@kgu.de];Rödel|, Franz(1);Balermpas|, Panagiotis(2);Winkelmann|, Ria(3);Rödel|, Claus(1);Fokas|, Emmanouil(1);
(1)University of Frankfurt, Department of Radiotherapy and Oncology, Frankfurt, Germany;(2)University Hospital Zürich, Department of Radiation Oncology, Zürich, Switzerland;(3)University of Frankfurt, Senckenberg Institute for Pathology, Frankfurt, Germany;
Show Affiliations

Congress Abstract

Dosimetric accuracy of MRCAT Pelvis, an MR-only simulation method for RT planning in the pelvic area

Authors: Bolard|, Grégory(1)*[gregory.bolard@latour.ch];
(1)Hôpital de La Tour, Radiotherapy, Meyrin, Switzerland;
Show Affiliations

Congress Abstract

Locally advanced nasopharyngeal carcinoma treated with a mixed beam (photons-protons) radiotherapy.

Authors:

Irene Turturici1, Giulia Marvaso1,2, Daniela Alterio1, Emma D'Ippolito3, Barbara Vischioni4, Sara Ronchi4, Maria Bonora4, Viviana Vitolo4, Edoardo Mastella5, Giuseppe Magro5, Pierfrancesco Franco6, Marco Krengli7, Piero Fossati8, Rosalinda Ricotti9, Sara Gandini10, Stefania Comi11, Anna Maria Camarda1, Eliana La Rocca1, Stefania Volpe1,2, Marta Tagliabue12, Elena Verri13, Ester Orlandi4, Barbara Alicja Jereczek-Fossa1,2, Roberto Orecchia14

1IEO European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy; 2University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy; 3Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Vision of Radiation Oncology, Napoli, Italy; 4Centro Nazionale di Adroterapia Oncologica, Clinical Radiotherapy Unit, Pavia, Italy; 5Centro Nazionale di Adroterapia Oncologica, Medical Physics Unit, Pavia, Italy; 6University of Turin, Department of Radiation Oncology, Torino, Italy; 7University of Piemonte Orientale, Department of Translation Medicine, Radiotherapy Unit, Novara, Italy; 8MedAustron Center for Ion Therapy and Research, Medical Department, Wiener, Austria; 9Centro Nazionale di Adroterapia Oncologica, Clinical Department-Bioengineering Unit, Pavia, Italy; 10IEO European Institute of Oncology IRCCS, Epidemiology and Biostatistics Unit, Milan, Italy; 11IEO European Institute of Oncology IRCCS, Unit of Medical Physics, Milan, Italy; 12IEO European Institute of Oncology IRCCS, Division of Head and Neck Surgery, Milan, Italy; 13IEO European Institute of Oncology IRCCS, Division of Urogenital and Head and Neck Tumors, Milan, Italy; 14IEO European Institute of Oncology IRCCS, Scientific Directorate, Milan, Italy

Show Affiliations

Congress Abstract

IMRT for recurrent nasopharyngeal cancer: OAR tolerance and acute toxicity

Authors: AISSAOUI|, Dorra(1)*[dorra.aissaoui@gmail.com];Mahjoubi|, Khalil(1);Essadok|, Ali(1);Abidi|, Rim(1);Nasr|, Chiraz(1);
(1)Salah Azaiz Institute, Radiation Oncology, Tunis, Tunisia;
Show Affiliations

Congress Abstract

Superparamagnetic iron oxide nanoparticles as radiosensitisers with magnetic fields.

Authors: RUSSELL|, Emily(1)*[erussell11@qub.ac.uk];Barry|, Miriam(2);Osman|, Sarah(1);Schettino|, Giuseppe(2);McGarry|, Conor(3);Prise|, Kevin(1);
(1)Queen's University Belfast, Centre for Cancer Research and Cell Biology, Belfast, United Kingdom;(2)National Physical Laboratory, Radiation Biology, London, United Kingdom;(3)Belfast Health and Social Care Trust, Radiotherapy Physics, Belfast, United Kingdom;
Show Affiliations
*:*